Shares in Spectrum Pharmaceuticals (SPPI) jumped 71% in extended trading after announcing positive topline results from a Phase 2 clinical trial evaluating its …
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is dealing with the rejection from yesterday’s FDA Oncology Advisory Committee meeting for its pipeline drug Qapzola (apaziquone), designed …
Analysts are weighing in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX), NY-based drug company Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and NV-based pharma company …
H.C.
In a research note published August 8, Roth Capital analyst Joseph Pantginis issued a note in which he reiterated a Buy rating on Spectrum …
In a research report released August 8, H.C.
In a research note issued today, H.C.
